MIRNA expression signature in classification of thyroid tumors
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ROSETTA GENOMICS
- Publication Date
- 2017-02-22
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to methods for the classification of thyroid tumors. In particular, the present invention relates to microRNA molecules associated with specific thyroid tumors.
[0002] Background of the invention
[0003] Accurate diagnosis of thyroid nodules continues to challenge physicians treating patients with thyroid disease. Diagnostic surgery is usually performed in patients with cytologically indeterminate nodules, although the majority of these nodules turn out to be benign after surgery. This limitation of FNA cytology in preoperative diagnosis leads to the clinical need for reliable preoperative molecular markers to distinguish benign from malignant thyroid nodules. MicroRNAs (miRs) are an important class of regulatory RNAs that have profound effects on a wide range of biological processes. These small (typically 18 to 24 nucleotides in length) noncoding RNA molecules can regulate protein expression patterns by promoting RN...